1. Polyclonal RB1 mutations and acquired resistance to CDK 4/6 inhibitors in patients with metastatic breast cancer. (11th December 2017) Authors: Condorelli, R; Spring, L; O'Shaughnessy, J; Lacroix, L; Bailleux, C; Scott, V; Dubois, J; Nagy, R J; Lanman, R B; Iafrate, A J; Andre, F; Bardia, A Journal: Annals of oncology Issue: Volume 29:Number 3(2018) Page Start: 640 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 1428PTesting for and frequency of molecular alterations in patients with advanced NSCLC in Germany. Results from the prospective German registry CRISP (AIO-TRK-0315). (23rd October 2018) Authors: Griesinger, F; Eberhardt, W E E; Nusch, A; Reiser, M; Bernhardt, C; Marschner, N; Jaenicke, M; Fleitz, A; Spring, L; Sahlmann, J; Karatas, A; Hipper, A; Weichert, W; Rittmeyer, A; Bischoff, H; Waller, C; Thomas, M Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗